Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00196352 · ClinicalTrials.gov registry record · Phase 3
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
A Phase 3 study of Contraception, sponsored by Duramed Research.
- Completed
- Registry status
- Phase 3
- Development phase
- 320
- Enrollment target
- 11
- Study locations
NCT00196352 is a Phase 3 study of Contraception that has completed, run by Duramed Research. The registered enrollment target is 320 participants, below the 450-participant average among 72 other Contraception trials with a reported enrollment target (29% lower). The trial reports 11 study locations across 9 states.
The verdict
NCT00196352, a Phase 3 study of Contraception, has completed, sponsored by Duramed Research.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 320 participants
- Enrollment target
- 11
- Study locations
Study Summary
This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.
Conditions Studied
Interventions
- DRUG Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets
Study Locations (11)
North Carolina
- Duramed Investigational Site - Charlotte
- Duramed Investigational Site - Winston-Salem
Virginia
- Duramed Investigational Site - Arlington
- Duramed Investigational Site - Norfolk
Arizona
- Duramed Investigational Site - Tucson
District of Columbia
- Duramed Investigational Site - Washington D.C.
Nebraska
- Duramed Investigational Site - Lincoln
New York
- Duramed Investigational Site - Rochester
Ohio
- Duramed Investigational Site - Columbus
Oklahoma
- Duramed Investigational Site - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 320 participants |
| Start Date | 2003-05 |
| Est. Completion | 2006-11 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00196352
The ClinicalTrials.gov registry entry for NCT00196352 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 450-participant average among 72 other Contraception trials with a reported enrollment target (29% lower). The listed sponsor is Duramed Research, which has 23 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets is the first listed.
NCT00196352 reports 11 study locations spanning 9 distinct geographic areas - top geographies include North Carolina, Virginia, Arizona.
Frequently Asked Questions
What is clinical trial NCT00196352 about?
NCT00196352 is a clinical study titled "A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.". This study is being conducted to evaluate the safety of ethinyl an extended-regimen oral contraceptive, with ethinyl estradiol supplementation during the usual hormone-free week, for up to an additional three consecutive years.
What is the current status of trial NCT00196352?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 320 participants. The study started on 2003-05. Estimated completion is 2006-11.
What conditions does trial NCT00196352 study?
This clinical trial studies the following conditions: Contraception.
What interventions are being tested in trial NCT00196352?
The interventions under investigation include: Levonorgestrel/EE 0.15/0.03 mg and EE 0.01 mg tablets (DRUG).
Who is sponsoring clinical trial NCT00196352?
This trial is sponsored by Duramed Research, which has 23 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00196352 being conducted?
This trial has 11 study locations across Arizona, District of Columbia, Nebraska, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy
ACTIVE NOT RECRUITING · Phase 3
-
A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles
COMPLETED · Phase 3
-
Study of Safety and Efficacy of an Oral Contraceptive
COMPLETED · Phase 3
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.